NOK 15 Million Secured Through A Guarantee Consortium For Biovotec

Biovotec AS secured the establishment of a guarantee consortium of targeted NOK 15 Million. The guarantee consortium builds on the company goals, and enables to move forward into human clinical studies. After only 3 weeks of actively establishing the consortium at the end of July, the targeted amount of the establishment was completed. “Having done this placement in only 3 weeks with a newly formed company is outstanding, especially when you consider that more than half the guaranteers are new to the Biovotec family.” - Ralf Schmidt, CEO at Biovotec

The signing of the guarantee consortium was conducted at a pre money valuation of NOK 150 million.


Featured Posts
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

Engebrets vei 3, 0275 Oslo, Norway                                                   © Biovotec AS                                                                       info@biovotec